Conference Paper

Critical Analysis of Electromagnetic Hyperthermia Randomized Trials: Dubious Effect and Multiple Biases

Table 1

Randomized clinical trials on superficial local hyperthermia published after 1990.

Trial Kapp et al. [7]Perez et al. [5] Emami et al. [8]Engin et al. [9]Vernon et al. [10]Overgaard et al. [11]Jones et al. [12]

Organization Stanford University Mallinckrodt Institute of Radiology Mallinckrodt Institute of Radiology Thomas Jefferson University Some European and Canadian centers Danish Cancer Society Duke University
CountryUSAUSAUSAUSAEurope/CanadaEuropeUSA
Year of publication1990199119921993199619962005
DesignMonocenter Monocenter Monocenter Monocenter Multicenter Multicenter Monocenter
Number of patients 703071734123670108
Number of tumors 179N/D 24044N/D 134N/D
Type of tumors Chest wall, neck nodes, melanoma Chest wall, neck nodes, melanoma Superficial Chest wall, neck nodes Chest wall Melanoma Chest wall, neck nodes, melanoma
Therapy
 HT+ RT + HT 42.5°C (6 HTs) RT + HT 42.5°C × 45–60′ (2 HTs) RT + HT 42.5°C (8 HTs) RT + HT 42.5°C (8 HTs) RT + HT 42.5°CRT + HT 43°C × 60′ (3 HTs)RT + HT 10 < CEM43°C   < 100 (10 HTs)
 HT− RT + HT 42.5°C (2 HTs) RT onlyRT + HT 42.5°C (4 HTs) RT + HT 42.5°C (4 HTs) RT onlyRT RT
Complete local response (%)
 HT+ 52%32%57.8%55%59%62% (immed.)/46% (2 yr)66%
 HT− 51%30%54.7%59%41%35% (immed.)/28% (2 yr)42%
Overall survival
 HT+ N/D Statistically insignificant Statistically insignificant N/D Statistically insignificant Statistically insignificant Statistically insignificant
 HT−
Disease-free survival
 HT+ N/D Enhanced N/D N/D Enhanced N/D Enhanced
 HT−
Burns
 HT+ N/D 30% N/D 40%11% N/D 46%
 HT− 0%40%2%5.7%
Complications (overall)
 HT+ 5% needed medication; 3% needed surgery N/D 18% of severe complications N/D Pain 27% pain, incl. 8% moderate and 6% severe 16% needed pause of treatment
Authors estimationNegativeNegativeNegativeNegativePositivePositivePositive
Final estimationNegativeNegativeNegativeNegativeDubiousDubiousDubious